Back

PTHrP buffers Wnt/Beta-catenin activity through a negative feedback loop to maintain articular cartilage homeostasis

Tong, W.; Hu, J.

2022-11-25 pathology
10.1101/2022.11.25.517940 bioRxiv
Show abstract

Osteoarthritis (OA) is the most common joint disease worldwide and a leading cause of disability. The Wnt/{beta}-catenin cascade is essential in articular cartilage development and homeostasis. It has proved that both overexpression and loss of {beta}-catenin lead to cartilage degeneration and OA symptoms. However, the mechanism of Wnt/{beta}-catenin balance in healthy cartilage remains unclear. In the present work, we confirmed that the Wnt/{beta}-catenin activation and PTHrP suppression in cartilage during the post-traumatic OA process. Then, we demonstrated that Wnt/{beta}-catenin upregulated PTHrP expression through binding to its promoter (P2), and induce mRNA (AT6) transcript expression, while PTHrP repressed Wnt/{beta}-catenin activity, and formed a Wnt/{beta}-catenin-PTHrP negative feedback loop in the very primary chondrocytes to maintain cartilage homeostasis. However, this negative feedback loop vanished in dedifferentiated chondrocytes, hypertrophic chondrocytes, and IL-1{beta} treated very primary chondrocytes. We further found that miR-106b-5p was increased in these "aberrant" chondrocytes and directly targeted PTHrP mRNA to abolish the feedback loop. PKC-{zeta} was activated by PTHrP through phosphorylation at Thr410/403, and subsequently induced {beta}-catenin phosphorylation and ubiquitination. Finally, we disclosed that exogenous PTHrP attenuated OA progression exogenous PTHrP attenuated OA progression. Together, these findings reveal that PTHrP is a vital mediator to keep Wnt/{beta}-catenin activity homeostasis in healthy cartilage through a negative feedback loop, and PTHrP might be a therapeutic target for OA and cartilage regeneration.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
eLife
5828 papers in training set
Top 0.6%
33.2%
2
PLOS ONE
5266 papers in training set
Top 30%
5.2%
3
Cells
249 papers in training set
Top 0.5%
4.3%
4
Acta Biochimica et Biophysica Sinica
23 papers in training set
Top 0.1%
4.3%
5
Stem Cell Research & Therapy
30 papers in training set
Top 0.1%
4.3%
50% of probability mass above
6
The FASEB Journal
194 papers in training set
Top 0.7%
4.0%
7
Osteoarthritis and Cartilage
32 papers in training set
Top 0.1%
4.0%
8
Journal of Cellular and Molecular Medicine
20 papers in training set
Top 0.1%
3.2%
9
International Journal of Molecular Sciences
494 papers in training set
Top 4%
2.8%
10
Arthritis Research & Therapy
15 papers in training set
Top 0.1%
2.4%
11
International Journal of Biological Sciences
10 papers in training set
Top 0.1%
1.9%
12
Journal of Bone and Mineral Research
35 papers in training set
Top 0.2%
1.5%
13
Science Advances
1243 papers in training set
Top 23%
1.3%
14
Frontiers in Cell and Developmental Biology
233 papers in training set
Top 3%
1.1%
15
Frontiers in Medicine
120 papers in training set
Top 3%
1.1%
16
iScience
1154 papers in training set
Top 25%
1.1%
17
Frontiers in Endocrinology
58 papers in training set
Top 1%
1.1%
18
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
26 papers in training set
Top 0.6%
1.1%
19
Molecular Therapy Nucleic Acids
39 papers in training set
Top 0.7%
1.1%
20
Scientific Reports
3612 papers in training set
Top 72%
0.9%
21
Biochemistry and Biophysics Reports
30 papers in training set
Top 1%
0.8%
22
Cancers
213 papers in training set
Top 5%
0.6%
23
Bioscience Reports
27 papers in training set
Top 2%
0.6%
24
RMD Open
14 papers in training set
Top 0.2%
0.6%
25
Science Bulletin
21 papers in training set
Top 0.5%
0.6%
26
Nature Communications
5641 papers in training set
Top 59%
0.6%
27
Life Sciences
27 papers in training set
Top 2%
0.6%